Implantable Remote Patient Monitoring Devices Market Report 2026

Implantable Remote Patient Monitoring Devices Market Overview

• Implantable Remote Patient Monitoring Devices market size has reached to $10.26 billion in 2025 • Expected to grow to $27.48 billion in 2030 at a compound annual growth rate (CAGR) of 21.7% • Growth Driver: Increasing Adoption Of Telehealth Services Fueling The Growth Of The Market Due To Rising Demand For Real-Time Chronic Disease Monitoring • Market Trend: New Implantable Monitor Uses AI To Cut False Arrhythmia Alerts • North America was the largest region in 2025.

What Is Covered Under Implantable Remote Patient Monitoring Devices Market?

Implantable remote patient monitoring devices refer to medical devices that are surgically placed inside a patient’s body to continuously monitor physiological parameters such as heart rhythm, blood pressure, or glucose levels. These devices utilize embedded sensors and wireless communication technology to continuously collect physiological data from within the body and transmit it remotely to healthcare providers, enabling real-time monitoring, early detection of health issues, and proactive medical intervention without frequent hospital visits. The main product types of implantable remote patient monitoring devices are blood glucose monitoring systems, cardiac monitoring devices, weight monitoring devices, and others. These find applications in cardiovascular diseases, neurological disorders, diabetes, and others, serving end users such as hospitals, ambulatory surgery centers, home care settings, and others.

What Is The Implantable Remote Patient Monitoring Devices Market Growth Forecast?

The implantable remote patient monitoring devices market size is expected to see exponential growth in the next few years. It will grow to $27.48 billion in 2030 at a compound annual growth rate (CAGR) of 21.7%. The growth in the forecast period can be attributed to technological advancements in implantable sensors, increasing prevalence of chronic diseases, integration with telemedicine platforms, rising geriatric population, supportive government reimbursement policies. Major trends in the forecast period include increasing adoption of continuous glucose monitoring devices, growth in implantable cardiac monitoring systems, rising use of smart weight monitoring devices, expansion of remote home care monitoring solutions, enhanced focus on real-time data transmission and patient safety.

What Is The Driver Of The Implantable Remote Patient Monitoring Devices Market?

The increasing adoption of telehealth services is expected to propel the growth of the implantable remote patient monitoring devices market going forward. Telehealth services are healthcare services provided remotely using phones, video calls, or apps, allowing patients to consult doctors without visiting a clinic or hospital. The increasing adoption of telehealth services is due to the growing demand for continuous and real-time health monitoring for patients with chronic conditions, as it enables timely medical interventions without frequent hospital visits. Telehealth services enhance implantable remote patient monitoring devices by enabling real-time data transmission between patients and healthcare providers, supporting timely medical decisions and reducing the need for in-person visits. They improve chronic disease management by offering continuous monitoring and early intervention, increasing healthcare efficiency and patient convenience. For instance, in April 2023, according to FAIR Health Inc., a US-based non-profit organization, in 2023, national telehealth use increased by 7.3%, rising from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Therefore, the increasing adoption of telehealth services is driving the growth of the implantable remote patient monitoring devices industry.

Key Players In The Global Implantable Remote Patient Monitoring Devices Market

Major companies operating in the implantable remote patient monitoring devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Dexcom Inc., LivaNova PLC, MicroPort Scientific Corporation, NeuroPace Inc., Profusa Inc., Senseonics Holdings Inc., Xeltis AG, GlySens Inc., Biotronik SE & Co KG, Impulse Dynamics NV, CVRx Inc., Vectorious Medical Technologies, EBR Systems Inc., Axonics Modulation Technologies Inc., Synchron Inc., Neuralink Corp, Orchestra BioMed Holdings Inc., Second Sight Medical Products Inc.

Global Implantable Remote Patient Monitoring Devices Market Trends and Insights

Major companies operating in the implantable remote patient monitoring devices market are focusing on developing advanced products, such as implantable cardiac monitors, to enhance targeting efficiency in monitoring for cardiac arrhythmias. An implantable cardiac monitor (ICM), also known as an implantable loop recorder (ILR), is a small device implanted just beneath the skin, typically on the left side of the chest, to continuously monitor and record the heart's electrical activity over an extended period. For instance, in June 2023, Biotronik AG, a Switzerland-based medical technology company, launched BIOMONITOR IV implantable cardiac monitor. It is a state-of-the-art ICM that pairs BIOTRONIK's SmartECG technology with artificial intelligence to reduce all false positive detections by 86% while preserving 98% of true episodes. This monitor is also capable of distinguishing between premature atrial contractions (PACs) and premature ventricular contractions (PVCs) to provide healthcare professionals with better tools for risk stratification and diagnosis.

What Are Latest Mergers And Acquisitions In The Implantable Remote Patient Monitoring Devices Market?

In September 2023, FluidAI Medical Inc., a Canada based healthcare technology company, partnered with Medtronic Canada ULC to enable at home remote patient monitoring. With this partnership, FluidAI Medical Inc., aims to scale its Stream platform to support remote patient monitoring and predictive analytics through Medtronic’s Continuous Connected Patient Care (CCPC) project, enabling seamless care transitions from hospital to home. Medtronic Canada ULC is a Canada-based healthcare technology company that specializes in medical devices, remote monitoring systems, and integrated digital care solutions.

What Defines the Implantable Remote Patient Monitoring Devices Market?

The implantable remote patient monitoring devices market consists of revenues earned by entities by providing services such as continuous health monitoring, early detection of health problems, remote data transmission, real-time alerts and reduced hospital visits. The market value includes the value of related goods sold by the service provider or included within the service offering. The implantable remote patient monitoring devices market also includes sales of implantable hemodynamic monitors, implantable pulmonary artery pressure sensors, insertable loop recorders (ILRs), subcutaneous electrocardiogram (ECG) monitors, and long-term heart rhythm monitoring devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Implantable Remote Patient Monitoring Devices Market Report 2026?

The implantable remote patient monitoring devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the implantable remote patient monitoring devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.